The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 02, 2015

Filed:

May. 25, 2012
Applicants:

Kenneth Luehrsen, South San Francisco, CA (US);

Mark Baer, South San Francisco, CA (US);

Christopher R. Bebbington, South San Francisco, CA (US);

David Martinez, South San Francisco, CA (US);

Varghese Palath, South San Francisco, CA (US);

Swathi Sujatha-bhaskar, South San Francisco, CA (US);

Nenad Tomasevic, South San Francisco, CA (US);

Jason Williams, South San Francisco, CA (US);

Geoffrey T. Yarranton, South San Francisco, CA (US);

Inventors:

Kenneth Luehrsen, South San Francisco, CA (US);

Mark Baer, South San Francisco, CA (US);

Christopher R. Bebbington, South San Francisco, CA (US);

David Martinez, South San Francisco, CA (US);

Varghese Palath, South San Francisco, CA (US);

Swathi Sujatha-Bhaskar, South San Francisco, CA (US);

Nenad Tomasevic, South San Francisco, CA (US);

Jason Williams, South San Francisco, CA (US);

Geoffrey T. Yarranton, South San Francisco, CA (US);

Assignee:

Kalobios Pharmaceuticals, Inc., South San Francisco, CA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); G01N 33/566 (2006.01); C07K 16/28 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/28 (2013.01); A61K 2039/505 (2013.01); C07K 2317/24 (2013.01); C07K 2317/34 (2013.01); C07K 2317/732 (2013.01);
Abstract

The invention provides anti-EGF-like module containing, mucin-like, hormone receptor-like 1 (EMR1) antibodies and methods of using such antibodies to treat EMR1-related diseases.


Find Patent Forward Citations

Loading…